Adalimumab treatment with and without methotrexate in patients with moderate to severe psoriatic arthritis: Results from adept

被引:0
|
作者
Kavanaugh, AF
Ritchlin, CT
Malaise, MG
Wordsworth, P
Birbara, CA
Weinberg, MA
机构
[1] UCSD, Ctr Innovat Therapy, Div Rheumatol Allergy & Immunol, La Jolla, CA USA
[2] Univ Liege, Dept Rheumatol, Liege, Belgium
[3] Univ Rochester, Sch Med & Dent, Rochester, NY USA
[4] Nuffield Orthopaed Ctr, Dept Rheumatol, Oxford OX3 7LD, England
[5] Univ Massachusetts, Sch Med, Worcester, MA USA
[6] Abbott Labs, Abbott Pk, IL 60064 USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:325 / 325
页数:1
相关论文
共 50 条
  • [31] TREATMENT OF PSORIATIC ARTHRITIS WITH ADALIMUMAB: APPLICATION OF A NEW COMPOSITE MEASURE OF MINIMAL DISEASE ACTIVITY USING DATA FROM ADEPT
    Mease, Philip J.
    Perdok, Renee
    Kary, Sonja
    Kupper, Hartmut
    [J]. RHEUMATOLOGY, 2010, 49 : I49 - I49
  • [32] Adalimumab radiographic efficacy in patients with psoriatic arthritis according to demographics, baseline clinical status, methotrexate use, and clinical response: Subanalysis of ADEPT.
    Gladman, D. D.
    Mease, P. J.
    Choy, E. H. S.
    Ritchlin, C. T.
    Wang, H.
    Sasso, E. H.
    [J]. ARTHRITIS AND RHEUMATISM, 2006, 54 (09): : S138 - S139
  • [33] Efficacy and safety of adalimumab for the treatment of peripheral arthritis in spondyloarthritis patients without ankylosing spondylitis or psoriatic arthritis
    Paramarta, Jacqueline E.
    De Rycke, Leen
    Heijda, Tanja F.
    Ambarus, Carmen A.
    Vos, Koen
    Dinant, Huib J.
    Tak, Paul P.
    Baeten, Dominique L.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 (11) : 1793 - 1799
  • [34] Does Concomitant Methotrexate with Adalimumab Influence Treatment Outcomes in Patients with Psoriatic Arthritis? Data from a Large Observational Study
    Behrens, Frank
    Koehm, Michaela
    Arndt, Uta
    Wittig, Bianca M.
    Greger, Gerd
    Thaci, Diamant
    Scharbatke, Eva
    Tony, Hans-Peter
    Burkhardt, Harald
    [J]. JOURNAL OF RHEUMATOLOGY, 2016, 43 (03) : 632 - 639
  • [35] EFFICACY AND SAFETY OF ADALIMUMAB FOR THE TREATMENT OF PERIPHERAL ARTHRITIS IN SPONDYLOARTHRITIS PATIENTS WITHOUT ANKYLOSING SPONDYLITIS OR PSORIATIC ARTHRITIS
    Paramarta, J.
    De Rycke, L.
    Heijda, T.
    Ambarus, C.
    Von, K.
    Dinant, H.
    Tak, P. P.
    Baeten, D.
    [J]. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2012, 30 (04) : 640 - 640
  • [36] Efficacy and Safety of Adalimumab for the Treatment of Peripheral Arthritis in Spondyloarthritis Patients without Ankylosing Spondylitis or Psoriatic Arthritis
    Paramarta, Jacqueline E.
    De Rycke, Leen
    Heijda, Tanja F.
    Ambarus, Carmen A.
    Vos, Koen
    Dinant, Huib J.
    Tak, Paul P.
    Baeten, Dominique L.
    [J]. ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : S235 - S235
  • [37] EFFICACY OF IXEKIZUMAB VERSUS ADALIMUMAB IN PSORIATIC ARTHRITIS (PSA) PATIENTS WITH AND WITHOUT MODERATE-TO-SEVERE PSORIASIS: 52-WEEK RESULTS FROM A MULTICENTRE, RANDOMISED OPEN-LABEL STUDY
    Kristensen, Lars-Erik
    Okada, Masato
    Tillett, William
    Leage, Soyi Liu
    El Baou, Celine
    Bradley, Andrew J.
    Meszaros, Gabriella
    de Vlam, Kurt
    [J]. RHEUMATOLOGY, 2021, 60
  • [38] Efficacy of Ixekizumab versus Adalimumab in Psoriatic Arthritis (PsA) Patients with and Without Moderate-to-severe Psoriasis: 52-week Results from a Multicentre, Randomised Open-label Study
    Kristensen, Lars Erik
    Okada, Masato
    Tillett, William
    Liu-Leage, Soyi
    El Baou, Celine
    Bradley, Andrew
    Meszaros, Gabriella
    de Vlam, Kurt
    [J]. ARTHRITIS & RHEUMATOLOGY, 2020, 72
  • [39] EFFICACY OF IXEKIZUMAB VERSUS ADALIMUMAB IN PSORIATIC ARTHRITIS (PSA) PATIENTS WITH AND WITHOUT MODERATE-TO-SEVERE PSORIASIS: 52-WEEK RESULTS FROM A MULTICENTRE, RANDOMIZED OPEN-LABEL STUDY
    Kristensen, Lars-Erik
    Okada, Masato
    Tillett, William
    Leage, Soyi Liu
    El Baou, Celine
    Bradley, Andrew
    Moszaros, Gabriella
    De Vlam, Kurt
    Mora Alfonso, Sergio Alexander
    [J]. JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2021, 27 : S140 - S141
  • [40] Efficacy of Ixekizumab Versus Adalimumab in Psoriatic Arthritis ( PsA) Patients With and Without Moderate-to- Severe Psoriasis: 52-Week Results from a Multicentre, Randomised Open-Label Study
    Kristensen, Lars-Erik
    Okada, Masato
    Tillett, William
    Liu-Leage, Soyi
    El Baou, Celine
    Bradley, Andrew
    de Vlam, Kurt
    Dutz, Jan
    [J]. JOURNAL OF RHEUMATOLOGY, 2021, 48 (07) : 1167 - 1168